News
October 12, 2018
IPHA is pressing the Irish Government and our MEPs to protect the IP incentives regime which is in danger of erosion by proposed legislation in Brussels. […]
October 9, 2018
As the Government announced the Budget today [Wednesday], the Irish Pharmaceutical Healthcare Association (IPHA) has said it was very disappointing that enough money could not be […]
September 12, 2018
Aidan Lynch, Vice President and General Manager of GSK (Ireland) Limited, has been elected as President of the Irish Pharmaceutical Healthcare Association (IPHA). In this position, […]
August 10, 2018
New Report Backs Biopharma Innovation as Enabler for New Treatments, Jobs and Investments, says IPHA
Protecting Ireland’s innovation policy environment is key to developing new medicines for patients, and to attracting fresh investments in pharmaceutical manufacturing and research, according to a […]
August 9, 2018
Seven new cancer medicines available in 12 EU countries – but not yet in Ireland Persistent delays approving medicines at odds with Government’s cancer outcomes targets […]
July 2, 2018
Agreement with Government delivers more savings than forecast – but approvals process for medicines remains slow and inefficient Price reductions take effect for 750 packs of […]
June 22, 2018
As Ireland signed up today [Friday] to the BeNeLuxA Initiative on pricing and supply of innovative medicines, the Irish Pharmaceutical Healthcare Association (IPHA) has said the […]